Cancer Screening Today

Trucheck Intelli Multi Cancer Screening Test

Trucheck Intelli from a local Guildford based company, Datar Cancer Genetics, is a revolutionary annual multi cancer screening test, based on a simple blood draw, for early detection of multiple cancers in asymptomatic individuals (aged 40 years or older).

It can detect 70 different types of cancer such as Melanoma, Head and Neck Cancer, Salivary Gland Cancer , Thyroid Cancer, Lung Cancer, Breast Cancer, Liver Cancer, Biliary Tract Cancer, Gastro-Intestinal Cancer, Soft Tissue Cancer and Osteosarcomas, Mesothelioma, Kidney Cancer, Bladder Cancer, Gynaecological Cancer, Male Cancers including Prostate Cancer, CNS Cancer, Thymus Cancer, Adrenal Cancer, Skin Cancer.

Europe witnesses around 4.4 million new cancer cases annually, with some diagnoses occurring in later, more advanced stages. Many cancers have no symptoms until the disease is advanced, and screening may help detect cancer early, when the chances of treatment success are high. Late detection often leads to more intensive and costly treatments, increasing the risk of side effects. Early identification is crucial for initiating less invasive treatments and achieving successful outcomes.

Trucheck is a cutting-edge, non-invasive, and comprehensive blood test designed to detect cancers through the identification of Circulating Tumor Cells (CTCs) and to analyse/identify organ/tissue of origin. Developed through years of collaborative international clinical research and innovation, Trucheck testing and technologies have undergone rigorous testing and earned FDA approval in the US. We can now choose to embrace the power of early detection for a path towards more effective, targeted interventions and improved patient outcomes.

Trucheck™* Intelli has been validated for the detection of following types of malignancies:

Adenocarcinoma (AD: Salivary Duct, Thyroid, Breast, lung, Oesophagus, Stomach, Duodenum,
Jejunum, Ileum, Colon, Rectum, Pancreas, Gallbladder, Bile Duct, Liver, Ovary, Prostate, Uterus);

Squamous Cell Carcinoma (SCC; Buccal Mucosa, Hard Palate, Larynx, Lip, Oral Cavity, Paranasal Sinus, Pharynx, Pyriform Fossa, Retromolar Trigone, Soft palate, Tongue, Tonsil, Oesophagus, Lung, Penis, Cervix, Vulva, Vagina, Anorectal, Skin);

Adenosquamous Carcinoma (ADSC: Oesophagus, Lung);

Neuroendocrine (NET: Lung, Esophagus, Duodenum, Jejunum, lleum, Thymus, Adrenal, Pancreas, Prostate, Colon, Rectum);

Renal Cell Carcinoma (RCC: Kidney);

Transitional Cell Carcinoma (CC: Bladder, Renal Pelvis, Ureter);

Gastrointestinal Stromal tumors (GIST: Stomach, Duodenum, lleum, Jejunum, Colon, Rectum);

Melanomas (Cutaneous, Mucosal);

Mesothelioma (Plural, Peritoneal);

Sarcomas (Carcinosarcoma, Chondrosarcoma, Leiomyosarcoma, Osteosarcoma, Liposarcoma);

Small Cell Lung Cancer (Lung);

Glioma.